Greg Siokas & Abbott Laboratories

Greg Siokas: Greg Siokas, CEO of Cosmos Health, commented on the acquisition, highlighting its role in strengthening the company's transition to proprietary product development and commercialization.

Abbott Laboratories: Abbott Laboratories S.A., a wholly owned subsidiary of Cosmos Health, acquired the international patent application and will lead the efforts in pursuing patent protection and expanding nanotechnology-based product development platforms.

Greg Siokas: Greg Siokas, CEO of Cosmos Health>>>, announced the successful testing and strategic importance of extending the C-Scrub brand into the veterinary sector.

Abbott Laboratories: Abbott Laboratories, a wholly owned subsidiary of Cosmos Health>>>, manufactures C-Scrub Wash 4% and will be responsible for the production of the veterinary formulation, leveraging its existing infrastructure.

Greg Siokas: Greg Siokas, CEO of Cosmos Health, announced the company's plan to monetize non-core assets, emphasizing the potential to unlock significant value for shareholders through acquisitions or debt reduction.

Abbott Laboratories: Abbott Laboratories is a manufacturing site owned by Cosmos Health, identified as a non-core real estate asset with a value of approximately $15 million that could be monetized.